Literature DB >> 33828428

High Prevalence of Low-Level Parasitemia With Plasmodium vivax in Makira-Ulawa Province Presents a Challenge for the Diagnosis and Eradication of Malaria in Solomon Islands.

James Fink1, Peter D Jones1.   

Abstract

Background: Malaria remains endemic in Solomon Islands, but data on malaria in the provinces of Solomon Islands are limited. This study from Makira-Ulawa Province aimed to identify the most prevalent strain of malaria and assess if the available rapid diagnostic test (RDT) was effective in Kirakira Hospital.
Methods: Forty-five patients who presented to Kirakira Hospital with symptoms of fever had a positive malaria parasite smear during a 4-week period in 2017. The parasite count for each smear was calculated. Simultaneous testing using the CareStart Malaria HRP2/pLDH (Pf/pan) Combo RDT was conducted. The data for all malaria parasite smears performed in Makira-Ulawa Province in 2016 were collated for comparison.
Results: All 45 patients diagnosed with malaria in a 4-week period in 2017 were positive for Plasmodium vivax. The median parasite load was 280 parasites per μL (range, 160 to 640 parasites per μL). None of the 45 CareStart RDTs performed was positive. In 2016, 5,505 of 17,195 patients (32.0%) screened had malaria parasites detected on a malaria parasite smear. P vivax was detected in 5,212 (94.7%) and Plasmodium falciparum in 285 (5.2%) of patients with malaria.
Conclusion: P vivax is the predominant strain of malaria present in Makira-Ulawa Province. RDTs were not helpful in the diagnosis of malaria at Kirakira Hospital. The parasite load detected in the 45 patients diagnosed with malaria in this study was low. A focus on attempting to eradicate P vivax in the community through improved compliance with treatment protocols is suggested as a possible way forward to best manage malaria in Makira-Ulawa Province. ©2021 by the author(s); Creative Commons Attribution License (CC BY).

Entities:  

Keywords:  Artemisinins; Melanesia; malaria; malaria–falciparum; malaria–vivax; point-of-care testing; primaquine

Year:  2021        PMID: 33828428      PMCID: PMC7993419          DOI: 10.31486/toj.20.0023

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  16 in total

Review 1.  Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!

Authors:  T K Mutabingwa
Journal:  Acta Trop       Date:  2005-09       Impact factor: 3.112

2.  A marked decline in the incidence of malaria in a remote region of Malaita, Solomon Islands, 2008 to 2013.

Authors:  Hellen Oloifana-Polosovai; John Gwala; Humpress Harrington; Peter D Massey; Elmer Ribeyro; Angelica Flores; Christopher Speare; Edwin McBride; David MacLaren; Rick Speare
Journal:  Western Pac Surveill Response J       Date:  2014-09-30

3.  Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.

Authors:  Melissa Kuwahata; Rushika Wijesinghe; Mei-Fong Ho; Anita Pelecanos; Albino Bobogare; Losi Landry; Hugo Bugora; Andrew Vallely; James McCarthy
Journal:  Malar J       Date:  2010-08-05       Impact factor: 2.979

Review 4.  The complexities of malaria disease manifestations with a focus on asymptomatic malaria.

Authors:  Dolie D Laishram; Patrick L Sutton; Nutan Nanda; Vijay L Sharma; Ranbir C Sobti; Jane M Carlton; Hema Joshi
Journal:  Malar J       Date:  2012-01-31       Impact factor: 2.979

5.  High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands.

Authors:  Andreea Waltmann; Andrew W Darcy; Ivor Harris; Cristian Koepfli; John Lodo; Ventis Vahi; David Piziki; G Dennis Shanks; Alyssa E Barry; Maxine Whittaker; James W Kazura; Ivo Mueller
Journal:  PLoS Negl Trop Dis       Date:  2015-05-21

6.  The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam.

Authors:  Mallika Imwong; Thuy Nhien Nguyen; Rupam Tripura; Tom J Peto; Sue J Lee; Khin Maung Lwin; Preyanan Suangkanarat; Atthanee Jeeyapant; Benchawan Vihokhern; Klanarong Wongsaen; Dao Van Hue; Le Thanh Dong; Tam-Uyen Nguyen; Yoel Lubell; Lorenz von Seidlein; Mehul Dhorda; Cholrawee Promnarate; Georges Snounou; Benoit Malleret; Laurent Rénia; Lilly Keereecharoen; Pratap Singhasivanon; Pasathorn Sirithiranont; Jem Chalk; Chea Nguon; Tran Tinh Hien; Nicholas Day; Nicholas J White; Arjen Dondorp; Francois Nosten
Journal:  Malar J       Date:  2015-09-30       Impact factor: 2.979

Review 7.  Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors.

Authors:  Qin Cheng; Jane Cunningham; Michelle L Gatton
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

8.  Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results.

Authors:  Araia Berhane; Mulugeta Russom; Iyassu Bahta; Filmon Hagos; Michael Ghirmai; Selam Uqubay
Journal:  Malar J       Date:  2017-03-06       Impact factor: 2.979

9.  Limitations of Rapid Diagnostic Testing in Patients with Suspected Malaria: A Diagnostic Accuracy Evaluation from Swaziland, a Low-Endemicity Country Aiming for Malaria Elimination.

Authors:  Nikhil Ranadive; Simon Kunene; Sarah Darteh; Nyasatu Ntshalintshali; Nomcebo Nhlabathi; Nomcebo Dlamini; Stanley Chitundu; Manik Saini; Maxwell Murphy; Adam Soble; Alanna Schwartz; Bryan Greenhouse; Michelle S Hsiang
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

10.  G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.

Authors:  Rosalind E Howes; Frédéric B Piel; Anand P Patil; Oscar A Nyangiri; Peter W Gething; Mewahyu Dewi; Mariana M Hogg; Katherine E Battle; Carmencita D Padilla; J Kevin Baird; Simon I Hay
Journal:  PLoS Med       Date:  2012-11-13       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.